Syntal Capital Partners’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25,697	Closed	-$2.34K	–	131
2020 Q4	$2.34K	Buy	+25,697	New	+$2.34K	0.29%	21